Top 5 things to know from our annual Drug Trends Report 2025
From the lasting economic ripple effects of the pandemic, to the impact of new global trade...
Health innovation
Insurers and benefits administrators
Article
Article
From insight to action: Dr. Lyle Oberg’s take on the future of Canadian care.
In a candid fireside chat at the 21st TELUS Health Annual Conference, Dr. Lyle Oberg, Executive...
Event and Webinar
TELUS Health Annual Conference 2024: How AI is reshaping the benefits landscape
Generative artificial intelligence (AI) is a "transformative milestone" that will change our world...
Article
The road ahead for pharmacogenomic testing
Pharmacogenomic (PGx) testing may have the potential to revolutionize prescription drug use in...
Article
Revitalizing health connectivity through AI
In a groundbreaking collaboration, TELUS Health and Clinia have revealed an exclusive strategic...
Article
Everything that’s happening with biosimilars in Canada
The slow but steady adoption of biosimilars is big news. With provinces increasingly making the...
Article
How can pharmacogenetics help control employee benefit costs?
Pharmacogenetics (also known as pharmacogenomics) is one of the most exciting frontiers of medical...
Article
Can technology create great plan member experiences?
Managing group health benefits costs, digitizing benefits delivery and data insights are key areas...
Report
Insights into the cost-effectiveness for cell and gene therapies
“Cell and gene therapies are some of the most exciting frontiers in modern medicine and have the...
Article
British Columbia’s biosimilars policy a turning point for private plans
B.C.’s Biosimilars Initiative has had a profound impact on private drug plans. By the end of 2020,...